Caricamento...
Eculizumab: A Review in Generalized Myasthenia Gravis
The humanized monoclonal antibody eculizumab (Soliris(®)) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with symptoms that are difficult to control with...
Salvato in:
| Pubblicato in: | Drugs |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845078/ https://ncbi.nlm.nih.gov/pubmed/29435915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-0875-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|